EPIDEMICS OF MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII IN BUENGKAN HOSPITAL, THAILAND, 2016 -2019
Keywords:
epidermics, MDR, XDR, Acinetobacter baumaniiAbstract
Acinetobacter baumanii is the serious in-hospital infectious pathogen around several countries in the world that including Thailand.The objective of this study is to identify the epidemiology of multi-drug resistant (MDR) Acinetobacter baumanii in Buengkan hospital from 1st January 2016 - 31th December 2019. The drug susceptility test was performed from total 615 patients that infected by A. baumanii by Kirby-Bauer disc diffusion to test with Aminoglycosides, Carbapenems, Fluoroquinolones, Beta-lactamase inhibitor,Extended-spectrum cephalosporins, and Folate pathway inhibitors. The study was analysed by descriptive statistcal analysis. The results are MDR A. baumanii 386 cases (62.76%) and mostly in the ICU. Trend of MDR A. baumanii was declined but the high virulence XDR A. baumanii was increased. In the overall nosocomial infection from A. baumanii are difficult to treat than the previous time and may increase the mortality of the patients. The new effective infection control intervention is the essential tool for prevention more seriously pathogen in the future.
References
Anuwat Keerasuntonpong, Chartchai Samakeenich, Chanwit Tribuddharat, Visanu Thamlikitkul. (2006). Epidemiology of Acinetobacter baumanii Infections in Siriraj Hospital 2002. Journal of Siriraj Med. 8(58): 951-953.
Crombach WH, Dijkshoorn L, van Noort-Klaassen M, et al. (1989). Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital. Journal of Intensive care medicine. 15(3): 166-170.
Inchai, J., et al. (2015). Risk factors of multidrugresistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 21(8): 570–574.
Lee NY, Lee HC, Ko NY, et al. (2007). Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Journal of Infection Control and Hospital Epidemiology. 28(6): 713-719.
Nattawat,T.,Pornpansa,P., etal. (2018). A Systematic Review of the Burden of Multidrug-Resistant Healthcare Associated Infections Among Intensive Care Unit Patients in Southeast Asia : The Rise of Multidrug-Resistant Acinetobacter baumannii. Journal of Infect control Hosp Epidemiol. 39(5): 525-533.
Nowak, J., et al. (2017). High incidence of pandrugresistant Acinetobacter baumannii isolates collected from patients with ventilatorassociated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. The Journal of antimicrobial chemotherapy. 72(12): 3277–3282.
Santimaleeworagun, W. (2007). Evidence and mechanisms of drug resistant Acinetobacter baumanii. Retrived January 15, 2021, fromhttp://www.prachanath.su.ac.th/tbps/tbps2007_1/tbps2007_1_161-176.pdf (in Thai).
Sieniawski, K., et al. (2013). Acinetobacter baumannii nosocomial infections. Journal of Polski przeglad chirurgiczny.85(9): 483–490.
Wisplinghoff H, Bischoff T, Tallent SM, et al. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Journal of Clinical Infectious Diseases. 39(3): 309-317.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
